Patent Assignment
Reel/Frame 051285/0295
Confirmatory Deed of Assignment Effective April 8, 2019
Recorded: 2019-12-13
Pages: 23
Assignor
ALCON PHARMACEUTICALS LTD.
Executed: 2019-11-11
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties
(15)
Compositions and Methods for Treating Otic, Ophthalmic and Nasal Infections
Patent:
6,509,327 →
Application:
09/575,850 →
Topical suspension formulations containing ciprofloxacin and dexamethasone
Patent:
6,284,804 →
Application:
09/636,563 →
Topical Suspension Formulations Containing Ciprofloxacin and Dexamethasone
Compositions and Methods for Treating Ophthalmic and Otic Infections
Methods for Treating Otic and Ophthalmic Infections
Olopatadine Formulations for Topical Administration
Ophthalmic Antibiotic Compositions Containing Moxifloxacin
Method of Treating Ophthalmic Infections with Moxifloxacin Compositions
Olopatadine Formulations for Topical Administration
Method of Treating Middle Ear Infections
Pharmaceutical Compositions Containing a Fluoroquinolone Antibiotic Drug
Olopatadine Formulations for Topical Nasal Administration
Method of Treating Middle Ear Infections
Method of Treating Middle Ear Infections
Method of Treating Middle Ear Infections
Related Assignments
(16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 2, 2010
From: ALCON RESEARCH, LTD.
To: ALCON, INC.
Reel/Frame 023883/0651 →
Assignment of Assignor's Interest
May 11, 2011
From: ALCON, INC.
To: ALCON PHARMACEUTICALS, LTD.
Reel/Frame 026263/0212 →
Merger
May 31, 2011
From: ALCON, INC.
To: NOVARTIS AG
Reel/Frame 026376/0076 →
Merger
Jun 3, 2011
From: ALCON, INC (F/K/A ALCON UNIVERSAL LTD.)
To: NOVARTIS AG
Reel/Frame 026393/0129 →
Assignment of Assignor's Interest
May 4, 2012
From: NOVARTIS AG
To: ALCON PHARMACEUTICALS LTD.
Reel/Frame 028155/0782 →
Assignment of Assignor's Interest
May 4, 2012
From: ALCON, INC.
To: ALCON PHARMACEUTICALS LTD.
Reel/Frame 028155/0624 →
Assignment of Assignor's Interest
Jul 11, 2013
From: NOVARTIS AG
To: ALCON PHARMACEUTICALS LTD.
Reel/Frame 030781/0375 →
Assignment of Assignor's Interest
Aug 11, 2015
From: NOVARTIS AG
To: ALCON PHARMACEUTICALS LTD
Reel/Frame 036301/0284 →
Assignment of Assignor's Interest
Jan 7, 2016
From: ALCON PHARMACEUTICALS LTD.
To: NOVARTIS AG
Reel/Frame 037432/0727 →
Assignment of Assignor's Interest
Jan 19, 2016
From: NOVARTIS AG
To: ALCON PHARMACEUTICALS LTD
Reel/Frame 037524/0780 →
Assignment of Assignor's Interest
Feb 3, 2022
From: NOVARTIS AG
To: HARROW HEALTH, INC.
Reel/Frame 058878/0919 →
Security Interest
Dec 15, 2022
From: HARROW HEALTH, INC.; HARROW EYE, LLC; HARROW IP, LLC; IMPRIMISRX, LLC
To: B. RILEY COMMERCIAL CAPITAL, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 062105/0556 →
Patent Security Agreement
Mar 30, 2023
From: HARROW HEALTH, INC.; HARROW IP, LLC
To: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 063205/0529 →
Termination and Release of Security Interest in Intellectual Property at Reel/Frame No. 62105/0556
Mar 30, 2023
From: B. RILEY COMMERCIAL CAPITAL, LLC, AS ADMINISTRATIVE AGENT
To: HARROW HEALTH, INC.; HARROW EYE, LLC; HARROW IP, LLC; IMPRIMISRX, LLC
Reel/Frame 063205/0889 →
Release of Security Interest
Sep 18, 2025
From: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
To: HARROW IP, LLC; HARROW HEALTH, INC.
Reel/Frame 072299/0660 →
Security Interest
Sep 26, 2025
From: HARROW, INC.; HARROW IP, LLC
To: FIFTH THIRD BANK, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 072384/0781 →